- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 609-623 of
1,261 results
2053 Exhibit: EX2053 Declaration of Smita Agarwal
Document
IPR2023-00724, No. 2053 Exhibit - EX2053 Declaration of Smita Agarwal (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2472 Exhibit: EX2472 Trijardy® XR Prescribing Information rev Jan 2020
Document
IPR2023-00724, No. 2472 Exhibit - EX2472 Trijardy® XR Prescribing Information rev Jan 2020 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2078 Exhibit: EX2078 Blüher, M et al, Dose response effects on HbA1c and bodywe...
Document
IPR2023-00724, No. 2078 Exhibit - EX2078 Blüher, M et al, Dose response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagonGLP 1 receptor agonist, compared with pl...
|
|
Cite Document
2073 Exhibit: EX2073 Novo Nordisk’s Ozempic 05 mg solution for injection in pre fil...
Document
IPR2023-00724, No. 2073 Exhibit - EX2073 Novo Nordisk’s Ozempic 05 mg solution for injection in pre filled pen, available at httpswwwmedicinesorgukemcproduct9750smpcgref last visited Jan...
|
|
Cite Document
2070 Exhibit: EX2070 NCT03144271, “Dose Escalation of Single Subcutaneous Do...
Document
IPR2023-00724, No. 2070 Exhibit - EX2070 NCT03144271, “Dose Escalation of Single Subcutaneous Doses of NNC 0113 0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacod...
|
|
Cite Document
2479 Exhibit: EX2479 Nordrum, A, 11 Blockbuster Drugs to Watch in 2015, Intl Bus...
Document
IPR2023-00724, No. 2479 Exhibit - EX2479 Nordrum, A, 11 Blockbuster Drugs to Watch in 2015, Intl Bus Times, httpwwwibtimescom11 blockbuster drugs watch 2015 1857100 Mar 24, 2015 (P....
|
|
Cite Document
2476 Exhibit: EX2476 Brenzavvy® Prescribing Information rev Jan 2023
Document
IPR2023-00724, No. 2476 Exhibit - EX2476 Brenzavvy® Prescribing Information rev Jan 2023 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2361 Exhibit: EX2361 National Institute of Diabetes and Digestive and Kidney Disea...
Document
IPR2023-00724, No. 2361 Exhibit - EX2361 National Institute of Diabetes and Digestive and Kidney Diseases, “Low Blood Glucose Hypoglycemia,” httpswwwniddknihgovhealth informationdiabe...
|
|
Cite Document
2101 Exhibit: EX2101 Marso, SP, et al, Semaglutide and Cardiovascular Outcomes...
Document
IPR2023-00724, No. 2101 Exhibit - EX2101 Marso, SP, et al, Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes, N Engl J Med, 3751834 1844 2016 (P.T.A.B. Jan. 17, ...
|
|
Cite Document
2068 Exhibit: EX2068 Victoza® Prescribing Information January 2010
Document
IPR2023-00724, No. 2068 Exhibit - EX2068 Victoza® Prescribing Information January 2010 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
1140 Exhibit: Exhibit 1140 Goland Dep
Document
IPR2023-00724, No. 1140 Exhibit - Exhibit 1140 Goland Dep (P.T.A.B. May. 22, 2024)
|
|
Cite Document
2422 Exhibit: EX2422 Jentadueto® Prescribing Information rev Aug 2017
Document
IPR2023-00724, No. 2422 Exhibit - EX2422 Jentadueto® Prescribing Information rev Aug 2017 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2427 Exhibit: EX2427 US Food Drug Administration, DrugsFDA, Nesina®
Document
IPR2023-00724, No. 2427 Exhibit - EX2427 US Food Drug Administration, DrugsFDA, Nesina® (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2469 Exhibit: EX2469 US Food Drug Administration, DrugsFDA, Stegluromet
Document
IPR2023-00724, No. 2469 Exhibit - EX2469 US Food Drug Administration, DrugsFDA, Stegluromet (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2411 Exhibit: EX2411 Kombiglyze® XR Prescribing Information rev Feb 2017
Document
IPR2023-00724, No. 2411 Exhibit - EX2411 Kombiglyze® XR Prescribing Information rev Feb 2017 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
